These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30808088)

  • 1. Pirometaxine™ (Narlisim™) in pediatric nasal congestion: a retrospective study.
    Tropi G; Patanè C; Leocata RC; Scatà D; Cannavò A; Palermo A
    Minerva Pediatr; 2019 Apr; 71(2):110-115. PubMed ID: 30808088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal decongestants in monotherapy for the common cold.
    Deckx L; De Sutter AI; Guo L; Mir NA; van Driel ML
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD009612. PubMed ID: 27748955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, double-blind, placebo-controlled study investigating the combination of acetylsalicylic acid and pseudoephedrine for the symptomatic treatment of nasal congestion associated with common cold.
    Loose I; Winkel M
    Arzneimittelforschung; 2004; 54(9):513-21. PubMed ID: 15500197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multicenter, Randomized, Placebo-Controlled Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold.
    Gelotte CK; Albrecht HH; Hynson J; Gallagher V
    J Clin Pharmacol; 2019 Dec; 59(12):1573-1583. PubMed ID: 31274197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
    Eccles R; Martensson K; Chen SC
    Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal decongestants for the common cold.
    Taverner D; Latte J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD001953. PubMed ID: 17253470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WITHDRAWN: Nasal decongestants for the common cold.
    Taverner D; Latte GJ
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD001953. PubMed ID: 19370573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold.
    Eccles R; Jawad MS; Jawad SS; Angello JT; Druce HM
    Am J Rhinol; 2005; 19(1):25-31. PubMed ID: 15794071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study.
    Meltzer EO; Ratner PH; McGraw T
    J Allergy Clin Immunol Pract; 2015; 3(5):702-8. PubMed ID: 26143019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An open label multi-center clinical trial to evaluate the efficacy of compound pseudoephedrine [corrected] hydrochloride sustained release capsules in patients with nasal symptoms associated with common cold].
    New Contac Multi-Center Clinical Cooperative Group ; Xiao Z
    Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):547-9. PubMed ID: 12421505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
    Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA
    Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal decongestants for the common cold.
    Taverner D; Latte J; Draper M
    Cochrane Database Syst Rev; 2004; (3):CD001953. PubMed ID: 15266459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W; Grubbe R; Weiss S; Lutsky B
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal decongestants for the common cold.
    Taverner D; Bickford L; Draper M
    Cochrane Database Syst Rev; 2000; (2):CD001953. PubMed ID: 10796673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
    Druce HM; Ramsey DL; Karnati S; Carr AN
    Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mometasone furoate nasal spray for moderate-to-severe nasal congestion in subjects with seasonal allergic rhinitis.
    Meltzer EO; Shekar T; Teper AA
    Allergy Asthma Proc; 2011; 32(2):159-67. PubMed ID: 21439168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-to-onset of cold and flu symptom relief: A randomized, double-blind, placebo-controlled pilot study for a multi-symptom combination product.
    Zhang Y; Mallefet P
    Int J Clin Pharmacol Ther; 2018 Dec; 56(12):604-611. PubMed ID: 30220290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the efficacy of a single dose of phenylephrine 10 mg compared with placebo in adults with acute nasal congestion due to the common cold.
    Kollar C; Schneider H; Waksman J; Krusinska E
    Clin Ther; 2007 Jun; 29(6):1057-70. PubMed ID: 17692721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nasal decongestant effect of xylometazoline in the common cold.
    Eccles R; Eriksson M; Garreffa S; Chen SC
    Am J Rhinol; 2008; 22(5):491-6. PubMed ID: 18655753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray.
    Gawchik S; Goldstein S; Prenner B; John A
    Ann Allergy Asthma Immunol; 2003 Apr; 90(4):416-21. PubMed ID: 12722964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.